PulseAugur
EN
LIVE 01:57:25
ENTITY AbbVie

AbbVie

PulseAugur coverage of AbbVie — every cluster mentioning AbbVie across labs, papers, and developer communities, ranked by signal.

Show in brief
Total · 30d
1
1 over 90d
Releases · 30d
0
0 over 90d
Papers · 30d
0
0 over 90d
TIER MIX · 90D
TOPICS
RELATIONSHIPS
SENTIMENT · 30D

1 day(s) with sentiment data

RECENT · PAGE 1/1 · 1 TOTAL
  1. RESEARCH · CL_109017 ·

    AbbVie buys Apogee for $10.9B; AI startup Cadence raises $100M

    AbbVie has acquired Apogee Therapeutics for $10.9 billion to bolster its immunology franchise with Apogee's lead drug, zumilokibart, which shows promise in treating autoimmune conditions. Separately, the AI startup Cade…